| Ytd | -23.30% | |
| 1y | -20.90% |
| Open | 5.09 | Prev Close | 5.08 | Low | 4.94 | High | 5.64 | Mkt Cap | 73.77M |
| Vol | 28.87K | Avg Vol | 10.35K | EPS | -0.08 | P/E | N/A | Forward P/E | 42.68 |
| Beta | 0.49 | Short Ratio | 20.86 | Inst. Own | 49.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-10 | 50-d Avg | 5.33 | 200-d Avg | 6.02 | 1yr Est | 8.00 |
Champions Oncology (NASDAQ:CSBR) reported fourth-quarter financial results on Monday. The transcript
Champions Oncology's first-quarter fiscal 2027 results record revenue and margin growth, stronger ad
Champions Oncology, Inc. (CSBR) Q1 2027 Earnings Call Transcript
Champions Oncology NASDAQ: CSBR reported first-quarter fiscal 2027 revenue growth, improved margins
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.05 per share. This is a 400 perce
Oncology services margin improves to 51%; Adjusted EBITDA increases to $671,000 HACKENSACK, NJ / ACC
New molecular imaging capabilities connect longitudinal radiopharmaceutical uptake with biodistribut
Champions Oncology reports fourth-quarter fiscal 2026 growth as revenue gains, margin improvement an
Champions Oncology, Inc. (CSBR) Q4 2026 Earnings Call Transcript
Champions Oncology NASDAQ: CSBR reported record revenue for fiscal 2026 and positive adjusted EBITDA
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analy
Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA HACKENSACK, NJ / ACCESS Newswire / J
Champions Oncology and Cytek Biosciences have different growth drivers and valuations, but which lif
CSBR and CEPL have levers in place for Gross Margin improvement.
Discover why Zacks rates Champions Oncology as "Neutral", being the first on Wall Street to initiate
HACKENSACK, NJ / ACCESS Newswire / July 20, 2026 / Champions Oncology, Inc. (NASDAQ:CSBR), a global
Champions Oncology, Inc. (NASDAQ: CSBR - Get Free Report) shares passed below its two hundred day mo
Eight studies demonstrate how clinically relevant models and integrated data can reduce translationa
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-genera
Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call Transcript
Company remains on track to deliver year-over-year revenue growth and positive adjusted EBITDA for t
HACKENSACK, NJ / ACCESS Newswire / March 5, 2026 / Champions Oncology, Inc. (CSBR), a leading transl
Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript
Stock News Ford pivots from full EV to hybrids and storage: Ford Motor (F) will discontinue the allâ
Investors are prepping for this week's earnings reports which include homebuilders, several appa
U.S. stocks fell on Friday, with the S&P 500 dropping over 1% and the Dow gaining 1.1%. The Fear
Stock futures up, focus on HYFT, ARGX, NAVN, AXR, CSBR as they report earnings. Top 2 energy stocks
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it
Companies Reporting Before The Bell • CSP (NASDAQ:CSPI) is likely to report earnings for its fourth
Companies Reporting Before The Bell • Koninklijke Philips (NYSE:PHG) is projected to report earning
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly
Companies Reporting Before The Bell • SAP (NYSE:SAP) is projected to report quarterly earnings a
This morning 279 companies reached new 52-week highs.
Companies Reporting Before The Bell • Celsius Holdings (NASDAQ:CELH) is estimated to report quar
This morning 180 companies set new 52-week highs.
Stocks That Hit 52-Week Lows On Monday
75 Biggest Movers From Yesterday
58 Biggest Movers From Yesterday
34 Stocks Moving In Wednesday's Mid-Day Session
51 Biggest Movers From Yesterday
64 Biggest Movers From Yesterday